{"name":"Tiburio Therapeutics","slug":"tiburio-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOcU1EcFNRUDRFRHJHYWZvVUw1ZEN6VnlZT2dFNWJ0dXRaZ2sxY1pld242RzJkY1NMMy1nZ0VaenJBbHBjMGtwZkpkUWVnNy1JOXdjVUVXX2VHZE5LSlM4dUtCWVY4VlZIREtrTHpLYzlZTktJdDh6d21QYm1VTDZTeGhibnFET1FIM29kR19jOWZKdk1aLXdTS0h6YmJVSklrenQxMHZR?oc=5","date":"2023-08-23","type":"pipeline","source":"Fierce Biotech","summary":"Rapport finds 'precision neuroscience' are the right words to talk investors into another $150M in mere months - Fierce Biotech","headline":"Rapport finds 'precision neuroscience' are the right words to talk investors into another $150M in mere months","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwJBVV95cUxQMFJBNk5hM2s4c3R5dUswblppeFNlVXBDTm5wbDM5RkN0bFVSa3pNR2UxQUpmMmkxZlliY3Y0OW5HdHRVV0Y4eDNYU2VBR2drTWJ2MUxTY195MEZFV3oyaTRlMFg4VGVWWmg1THVDQ0hxWWZfWjQ2U0tZa1ZVQ3lGN1pzdTlRbWFrekZ4dmFubkI3RFBmYlhQVHBhOEIzclU0a3p3N09hMUVuTkN2dGkzSzVVOHZMckVYMVEwcVB5YTZ5VTFmTWtxN0YwbHpvQUNhemRsc2hUTW91RnI2Wjh6SndUUWxKMnU5WG01RFFqMHV2Vm9rWE5ULW9yOGN4cXN4dTRzRFp0MDFFVV82Z1FLSXFzRDhPdGFmY25DMXlpUy02ZEpfQ2RJY3BRb25Rb1A3eTdBZkdjaGZTbGUzd21r?oc=5","date":"2023-03-07","type":"pipeline","source":"Business Wire","summary":"Rapport Therapeutics Launches with $100 Million to Transform the Treatment of Neurological Disease through the Discovery and Development of Precision Therapies - Business Wire","headline":"Rapport Therapeutics Launches with $100 Million to Transform the Treatment of Neurological Disease through the Discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNWnZOWTl3NnlvbC16QS1VX1dLRzQtV2dDaDlUZ0tnOG96S2t2N3FlaGJGengwMU1kMGVGdHJEa2VVdlFlZDhoVTR3XzViNjdpOWR2QkwwYVRtcjk0Mk9SbnczWExXdUNzRF81anVZdUFONWlmWVlHNC1lWjB4MHJTZ3lwcVlhcm52S1V5Zm4zVF94NnVTV0o0QW5QOA?oc=5","date":"2023-03-07","type":"pipeline","source":"BioPharma Dive","summary":"J&J-backed startup launches with $100M to build better brain drugs - BioPharma Dive","headline":"J&J-backed startup launches with $100M to build better brain drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPOVhjQ3FFaHRPbEt2b0U3c1FObGJPLVRUWVNUUU5YZTRiUU5jN3VGM01raHVrdWl6cFZZNDNmNlU1MFBDQmVjN1RBN2wzWnFrREhmRW5qcFJxbjhXaXZoa0wxRnM1di1KUXBzOEMwX1ZtVVRxNVc2ZnN1TzJpTTlYbk9kUjVFTElzQ2dpeFlLUW81WXFoLXFPN3k1ZG1GTHE0ckZDeTFKYmE1a1BQWHlKVElEY2ZOZThXUllEYXBwZ2xNYnRD?oc=5","date":"2023-03-07","type":"pipeline","source":"Fierce Biotech","summary":"Third Rock, J&J spinout Rapport arrives with $100M and ambition to transform precision neuroscience - Fierce Biotech","headline":"Third Rock, J&J spinout Rapport arrives with $100M and ambition to transform precision neuroscience","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQUk1iRjBoa05XNWhTMlJrbE1xY1R0TTZ5TGd0anB1cU9Udy1YMU5uV1lsU1BJc1U5NlBycG5KQUpiU0R6QW42b0piV0pXS1pBXzBsMUNsdWdPVDIzeDRmQjU5ZUw3UWJJaTdvNnMzcFVGX3ViTmZ5R2lPa19Ua2wtT0RiamE2YTZTd29FN0ZRMm1jcVRn?oc=5","date":"2022-04-18","type":"pipeline","source":"BioPharma Dive","summary":"Imara to reduce staff by 83% amid biotech shakeout - BioPharma Dive","headline":"Imara to reduce staff by 83% amid biotech shakeout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9fenFYWGxqX0J1eWpGRDBlejlEdmxpWTZlVlhnVVRfdzRTWlhCeUwtdzhNUUFBdVhZVjdVOW9Ia3RYb3VVMVJLbW02VlRxd2VsLVB1R19WNnVYUkI5bkFOZzBucFN6emNhaFZz?oc=5","date":"2020-12-10","type":"pipeline","source":"BioSpace","summary":"BioSpace Movers & Shakers, Dec. 11 - BioSpace","headline":"BioSpace Movers & Shakers, Dec. 11","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1CTl9LNm92ekxYeVhDR2F0TlVUcVVGMmxyVlRNN0lYUk84c0pRaDZrMS1VdnpRMVZrNmJpbjdscndfSjZNcXhVcE83U0hzTnluYk1wRnJkNEdDbGFOWllPcmJSU0Q3N1hYYXh4dkNEZzhwckNjRnEweG13?oc=5","date":"2020-01-03","type":"pipeline","source":"BioSpace","summary":"Top Life Sciences Startups to Watch in 2020 - BioSpace","headline":"Top Life Sciences Startups to Watch in 2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOOEpRUW15dHdHc0ZWaVoxaUlmUHNlbTM5U1QySmtIVG04YzFFdG56aFJ2T096b2EwQm9xRDY1Q1I5NE9KV09lU2R1SjhOMV9PY1hRMU5Xc0c2Qm5OUlpSNWt6Y29oV2VFRTF0UGRXcTdfa2o4WGp5UFc5UWFfTlZDQ3JXMFM5Q2E1cjl2aUNPZVZBUXNoNF9WZ3FiSGR3QTB2WEVkbE9jdDVzY00yUmRadElB?oc=5","date":"2019-03-15","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Novartis' Sandoz chief exits, fueling spinoff and sale rumors - Fierce Biotech","headline":"Chutes & Ladders—Novartis' Sandoz chief exits, fueling spinoff and sale rumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPU3dYZkJ3ZmZfUHU5dlBjNG5Xb0pHeTI1U2RFRk5IejRhZjZMd1FVNWE2cFkzVDNuazNPRm8zZ1V2amN6NWpNQm14dnNGam9WTkRGMXFHb3VvZGxfSjJKMVJBM1FhWE1wYzBkc2tPazBXU0oweDYyT2FMX0lSSWpuc01TaUFPV1U2RzVyQWxtY0NwdXVCR2JwX1pnNlZFRGc?oc=5","date":"2019-03-12","type":"pipeline","source":"BioSpace","summary":"Tiburio Therapeutics Inc. Appoints Nerissa Kreher, MD, Chief Medical Officer - BioSpace","headline":"Tiburio Therapeutics Inc. Appoints Nerissa Kreher, MD, Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOSXBFM1A4X2dCNk1JcHVWa1JUQUFCRS1yZWRPQnV2eXZodFd0NkFsRTFMRXRQdVVlZ0MzalQzWHJsRmdsaEpnaGk1VUtQb2ZIZ3duTmNrYmtmSjFGUE54Nnd5WkZlS3F4S0k4NU9UOVBReVdxSGpsOXd0SFIxUVcweWF6VmVvUHNaS0g4bm5DVXhJQms5RE51Z1Zzb3lMM0t3R285dGZjWDBxX0x6R3huUGpHall5NTR1QzB4Xw?oc=5","date":"2019-01-03","type":"pipeline","source":"BioSpace","summary":"Tiburio Launches With $31 Million and Two Compounds From Ipsen Targeting Rare Endocrine Diseases - BioSpace","headline":"Tiburio Launches With $31 Million and Two Compounds From Ipsen Targeting Rare Endocrine Diseases","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}